Sugar Control

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

chromium picolinate, Quantity: 402.25 microgram (Equivalent: chromium, Qty 50 microgram); chromic chloride hexahydrate, Quantity: 768.84 microgram (Equivalent: chromium, Qty 150 microgram); Trigonella foenum-graecum, Quantity: 125 mg (Equivalent: Trigonella foenum-graecum, Qty 500 mg); heavy magnesium oxide, Quantity: 55.28 mg (Equivalent: magnesium, Qty 32 mg); Biotin, Quantity: 4 mg; Cinnamomum verum, Quantity: 50 mg (Equivalent: Cinnamomum verum, Qty 500 mg; Equivalent: coumarin, Qty 0.0005 mg); Gymnema sylvestre, Quantity: 100 mg (Equivalent: Gymnema sylvestre, Qty 2 g; Equivalent: gymnemic acids (of Gymnema sylvestre), Qty 25 mg)

Available from:

Wellwisse Pharmaceuticals Pty Ltd

INN (International Name):

Biotin,chromic chloride hexahydrate,Chromium picolinate,Cinnamomum verum,Gymnema sylvestre,heavy magnesium oxide,Trigonella foen

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: Carnauba Wax; calcium hydrogen phosphate dihydrate; maltodextrin; hypromellose; titanium dioxide; croscarmellose sodium; colloidal anhydrous silica; crospovidone; chlorophyllin-copper complex; macrogol 8000; magnesium stearate; povidone; microcrystalline cellulose

Administration route:

Oral

Therapeutic indications:

Maintain/support general health and wellbeing ; Maintain/support nail health/strength/thickness ; Helps maintain/support healthy blood sugar/glucose ; Maintain/support cardiovascular system health ; Maintain/support healthy cardiovascular system function ; Aid/assist/helps glucose/sugar/carbohydrate metabolism ; Helps prevent dietary (state vitamin/mineral/nutrient) deficiency

Product summary:

Visual Identification: ;

Authorization status:

Licence status A

Authorization date:

2016-04-15